The largest database of trusted experimental protocols

251 protocols using mission shrna

1

Lentivirus Production and Transduction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nonreplicative VSV-g pseudotyped lentiviral particles were produced by transfecting HEK-293T cells with Gag, Pol, rev, encoding plasmid (pPAX2), envelop encoding plasmid (pMD2.G), and either the HA-Tev-LAT construct (Larghi et al., 2013 (link)) encoded in a pWXLD vector, or the SNAP-GalT-GFP construct (Johannes and Shafaq-Zadah, 2013 (link)) encoded in a pCDH-EF1-MCS-IRES-Puro vector (SBI System Biosciences), or shRNA sequences encoded in pLKO.1 plasmid. shC (Mission shRNA SHC002; Sigma-Aldrich), VAMP7-specific shRNA, sh1 (Mission shRNA, TRCN0000059888; Sigma-Aldrich) and sh5 (Mission shRNA, TRCN0000059892; Sigma-Aldrich), Rab6a/a′-specific shRNA, sh6 (Mission shRNA, TRCN0000379588; Sigma-Aldrich) and sh7 (Mission shRNA, TRCN0000379794; Sigma-Aldrich) and Syntaxin-16–specific shRNA, sh1 (Mission shRNA, TRCN0000229991; Sigma-Aldrich), and sh5 (Mission shRNA, TRCN0000161930; Sigma-Aldrich) were used. Lentivirus were recovered in supernatant after 2 d and concentrated. 5 × 106 Jurkat T cells were infected for 24 h, when silenced cells were selected in puromycine (2 µg/ml; Invivogen) and used 5 d after infection.
+ Open protocol
+ Expand
2

Generating Lentiviral Knockdown Vectors

Check if the same lab product or an alternative is used in the 5 most similar protocols
MUC1shRNA (MISSION shRNA TRCN0000122938; Sigma) or a control scrambled shRNA (CshRNA; Sigma) was inserted into the pLKO-tet-puro vector (Plasmid #21915; Addgene, Cambridge, MA, USA). MUC1-C(AQA) cDNA was inserted into the pinducer20 vector (Plasmid #44012; Addgene). The CshRNA, MUC1shRNA, NF-κB p65shRNA (MISSION shRNA TRCN0000014685; Sigma), STAT3shRNA (MISSION shRNA TRCN0000020543; Sigma) and TWIST1shRNA (MISSION shRNA TRCN0000329811; Sigma) vectors were produced in HEK293T cells as described (18 (link)). Cells transduced with the vectors were selected for growth in 1-3 μg/ml puromycin or 100 μg/ml geneticin.
+ Open protocol
+ Expand
3

Lentiviral transduction of Jurkat T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nonreplicative VSV-g pseudotyped lentiviral particles were produced by transfecting HEK-293T cells with Gag, Pol, rev, encoding plasmid (pPAX2), envelop encoding plasmid (pMD2.G) and either the HA-Tev-LAT construct [13 (link)] encoded in a pWXLD vector, or the SNAP-GalT-GFP construct [29 (link)] encoded in a pCDH-EF1-MCS-IRES-Puro vector (SBI System Biosciences, Embarcadero Way, Palo Alto, CA, USA), or short hairpin RNA (shRNA) sequences encoded in pLKO.1 plasmid: Nontargeting control shRNA (shC, Mission shRNA SHC002, Sigma-Aldrich, St. Louis, MO, USA), GMAP210 shRNA (Mission shRNA, TRCN0000022021, Sigma-Aldrich, St. Louis, MO, USA), VAMP7 shRNA (Mission shRNA, TRCN0000059892, Sigma-Aldrich, St. Louis, MO, USA), Rab6 shRNA (Mission shRNA, TRCN0000379588, Sigma-Aldrich, St. Louis, MO, USA), and Synt16 shRNA (Mission shRNA, TRCN0000161930, Sigma-Aldrich, St. Louis, MO, USA). Lentivirus were recovered in supernatant after 2 days and concentrated. 5 × 106 Jurkat T cells were infected for 24 h, cells infected with shRNA encoding virus were selected in puromycin (2 µg/mL, ant-pr, InvivoGen, Toulouse France) and used 4 days postinfection.
+ Open protocol
+ Expand
4

Lentiviral Particle Production and Transduction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Non-replicative VSV-g pseudotyped lentiviral particles were produced by transfecting HEK-293T cells with Gag, Pol, rev, encoding plasmid (pPAX2), envelop encoding plasmid (pMD2.G) and either the HA-Tev-LAT construct (Larghi, P. 2013) encoded in a pWXLD vector, or the SNAP-GalT-GFP construct 29 encoded in a pCDH-EF1-MCS-IRES-Puro vector (SBI System remix, or adapt this material for any purpose without crediting the original authors. preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share, reuse, Biosciences), or short hairpin RNA (shRNA) sequences encoded in pLKO.1 plasmid: Nontargeting control shRNA (shC, Sigma-Aldrich, Mission shRNA SHC002), GMAP210 shRNA (Sigma-Aldrich, Mission shRNA, TRCN0000022021), VAMP7 shRNA (Sigma-Aldrich, Mission shRNA, TRCN0000059892), Rab6 shRNA (Sigma-Aldrich, Mission shRNA, TRCN0000379588), and Synt16 shRNA (Sigma-Aldrich, Mission shRNA, TRCN0000161930). Lentivirus were recovered in supernatant after 2 days and concentrated. 5 × 10 6 Jurkat T cells were infected for 24 h, cells infected with shRNA encoding virus were selected in puromycin (2 µg/mL, InvivoGen, ant-pr) and used 4 days post infection.
+ Open protocol
+ Expand
5

Engineered Cell Lines for MUC1 and MYC Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
MUC1shRNA#1 (MISSION shRNA; Sigma, TRCN0000122938), MUC1shRNA#2 (MISSION shRNA; Sigma, TRCN0000122937), MYCshRNA (MISSION shRNA; Sigma, TRCN0000039642) or a control scrambled CshRNA (Sigma) was inserted into the pLKO-tet-puro vector (Addgene, Cambridge, MA, USA; Plasmid #21915). The viral vectors were produced in HEK293T cells as previously described (60 ; 61 (link)). BT-549, A549, H460, BT-20 and MDA-MB-468 cells expressing tet-MUC1shRNA#1, MDA-MB-231 cells expressing tet-MUC1shRNA#2 and cells expressing tet-MYCshRNA or tet-CshRNA were selected for growth in 1–3 μg/ml puromycin. Cells were treated with doxycycline (DOX; Sigma, St. Louis, MO, USA).
+ Open protocol
+ Expand
6

Engineered Cell Lines for MUC1 and MYC Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
MUC1shRNA#1 (MISSION shRNA; Sigma, TRCN0000122938), MUC1shRNA#2 (MISSION shRNA; Sigma, TRCN0000122937), MYCshRNA (MISSION shRNA; Sigma, TRCN0000039642) or a control scrambled CshRNA (Sigma) was inserted into the pLKO-tet-puro vector (Addgene, Cambridge, MA, USA; Plasmid #21915). The viral vectors were produced in HEK293T cells as previously described (60 ; 61 (link)). BT-549, A549, H460, BT-20 and MDA-MB-468 cells expressing tet-MUC1shRNA#1, MDA-MB-231 cells expressing tet-MUC1shRNA#2 and cells expressing tet-MYCshRNA or tet-CshRNA were selected for growth in 1–3 μg/ml puromycin. Cells were treated with doxycycline (DOX; Sigma, St. Louis, MO, USA).
+ Open protocol
+ Expand
7

Lentiviral Knockdown of ADAM15 and Claudin-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
pLKO.1/puromycin plasmids encoding Mission shRNA (Sigma) sequences were used (table 4 in Supplementary Information). Additionally, an shRNA sequence targeting the 3′ UTR of ADAM15: FWD 5′-CCGGGTTGGACGGGATTGAGGAACTCGAGTTCCTCAATCCCGTCCAACTTTTTG-3′ REV 5′-AATTCAAAAAGTTGGACGGGATTGAGGAACTCGAGTTCCTCAATCCCGTCCAAC-3′, was cloned into pLKO.1 using AgeI and EcorRI restriction sites. The positive clones were selected by XhoI digest according to Sigma Mission shRNA protocol. Lentiviral particles were produced according to Sigma Mission shRNA protocol. Stable downregulation of Claudin-1 or ADAM15 was achieved by 1 µg/mL puromycin selection.
+ Open protocol
+ Expand
8

Organoid-based Genetic Manipulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the shRNA knockdown experiment, an equal number of APCKO organoids were transduced with lentiviral shRNA constructs against either control (SHC002, MISSION shRNA, Merck,) or BCL-XL (TRCN0000033500, MISSION shRNA, Merck) by spin transduction. Briefly, organoids were collected and trypsinized using TrypLE Express (Thermo Fischer Scientific) for 3 min at 37 °C. Following dissociation, cells were washed, counted, and seeded into 48-well plates in organoid medium (see above) containing 10 µM ROCK inhibitor (Sigma-Aldrich), 8 µg/ml polybrene (Sigma-Aldrich), and 50 µL concentrated virus (AMICON Ultra-15 100k filters, Merck, Schiphol-Rijk, The Netherlands). Plates were spun down at 32 °C for 1 h at 1800 rpm. After ON incubation, cells were collected by washing with PBS and spun down and either processed for RNA extraction or seeded into Matrigel (Corning) for measuring outgrowth. APCKO organoids were transduced with lentiviral pHEFTIR-EV (empty vector) or pHEFTIR-BCL-XL (overexpressor) constructs [16 (link)] and selected by sorting for the RFP positive population. APCKO organoids were transduced with lentiviral microRNA inhibitors (Merck) targeting hsa-miR-17-5p (HLTUD0264), hsa-miR18a-3p (HLTUD0292), and a negative control cel-mir-243-3p (HLTUD002C). Transduced cells were selected with 4 µg/ml puromycin (InvivoGen, Toulouse, France) for 7 days.
+ Open protocol
+ Expand
9

Sema7a Regulation of EMT6 Metastasis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To characterize the role of Sema7a on EMT6 metastasis WT mice were employed that were treated with non-target control (Sigma-Aldrich, MISSION ShRNA, SHC002) or validated Sema7a-specific shRNA (Sigma-Aldrich, MISSION ShRNA, TRCN0000067540) via intratracheal (i.t.) inoculation (107 virion/mouse).
+ Open protocol
+ Expand
10

Stable CXCR4 Knockdown in GL26-Cit Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To knockdown CXCR4 in GL26-Cit cells, pLKO.1-puro lentiviral plasmids encoding four different shRNA hairpins constructs specific for mouse CXCR4 (NM_009911) along with puromycin resistance cassette were purchased from Sigma Aldrich as part of the mission shRNA Consortium. Each shRNA clone was tested for its' ability to knockdown CXCR4 expression. Second-generation lentiviruses encoding two shRNA constructs (TRCN0000028704, CXCR4 shRNA1 and TRCN0000028749, CXCR4 shRNA2) were prepared according to manufacturer's instructions (Clonetech_LentiXTX transfection kit). (Cat# 631317). 5 x106 HEK293TX cells were seeded 24 hours prior to transfection with each of the shRNA construct along with Lenti-X HTX packaging mix, then cells were incubated for 48 hours at 37°C. Lentiviral particles were purified from culture supernatant. GL26-Cit cells were infected with purified mouse CXCR4–specific shRNA lentivirus for 48-72 hours and subjected to puromycin selection for 2 weeks. A western blot analysis was performed to validate stable CXCR4 knockdown in GL26-Cit cell line. Similar methodology was used to create GL26-Cit-NT control cell-line, which consisted pLKO.1-puro lentiviral expression vector and non-targeting shRNA hairpin construct (mission shRNA, Cat#:SHC002, Sigma-Aldrich).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!